← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2010Last known activity
Jan 31, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 6 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT05664568Lead sponsorPhase 2Jan 31, 2023
- NCT05664568Reponsible party - principal investigatorPhase 2Jan 31, 2023
- NCT05664568Sponsor investigatorPhase 2Jan 31, 2023
- NCT05509153Reponsible party - principal investigatorPhase 2Nov 1, 2022
- NCT05509153Lead sponsorPhase 2Nov 1, 2022
- NCT05509153Overall official - principal investigatorPhase 2Nov 1, 2022
- NCT05401409CollaboratorN/AMay 5, 2022
- NCT05401409Lead sponsorN/AMay 5, 2022
- NCT05401409Overall official - principal investigatorN/AMay 5, 2022
- NCT05401409Reponsible party - principal investigatorN/AMay 5, 2022
- NCT02004782Sponsor investigatorPhase 4Jun 1, 2014
- NCT02004782Lead sponsorPhase 4Jun 1, 2014
- NCT02004782Overall official - principal investigatorPhase 4Jun 1, 2014
- NCT01075802Lead sponsorN/AMar 1, 2010
- NCT01075802Reponsible party - principal investigatorN/AMar 1, 2010
Details
- Last known activity
- Jan 31, 2023